Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycatedhaemoglobin as a dual biomarker
Background: Patients with type 2 diabetes have an increased prevalence of lipid abnormalities, contributing to their high risk of cardiovascular diseases (CVD).Glycated hemoglobin (HbA1c) is a routinely used marker for long-term glycemic control. In accordance with its function as an indicator for...
Main Author: | Badri Fadhil Alnidawi |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Baghdad/ Al-Kindy College of Medicine
2015-12-01
|
Series: | مجله كليه طب الكندي |
Subjects: | |
Online Access: | https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/360 |
Similar Items
-
Glycated haemoglobin as a dual biomarker Association between HbA1c and dyslipidemia in type 2 diabetic patients
by: Ikhlas K. Hammed, et al.
Published: (2012-04-01) -
Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study
by: Alzahrani SH, et al.
Published: (2019-08-01) -
Evaluation of Role of Prognostic Factors on Hearing Outcome in Unilateral Idiopathic Sudden Onset Sensorineural Hearing Loss
by: Namrata Yadav, et al.
Published: (2023-09-01) -
Investigating the biochemical association of gestational diabetes mellitus with dyslipidemia and hemoglobin
by: Muhammad Sajid Hamid Akash, et al.
Published: (2023-10-01) -
Biomarkers of Glyco-Metabolic Control in Hemodialysis Patients: Glycated Hemoglobin vs. Glycated Albumin
by: Francesca Gabriela Martino, et al.
Published: (2021-07-01)